Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Bone Drug Reduces Breast Cancer Relapse

Women on Zometa had 35% less chance of having tumor again

By Harry Kimball,  Newser Staff

Posted May 31, 2008 7:21 PM CDT

(Newser) – A drug designed to protect cancer patients' bones also renders breast cancer relapses less likely, a new study says. Funded in part by the drug's maker, Novartis, researchers found that even two injections of Zometa a year cut tumor recurrence by 35% in more than 1,800 pre-menopausal women.

About 6% of women who took Zometa suffered a tumor relapse, compared to 9% who didn't. A doctor unaffiliated with the study warned women not to gobble up the drug, but said that “within the narrowly defined group of women who got the drug, this study would give one strong impetus to use Zometa.''

A production plant of Swiss pharma giant Novartis.
A production plant of Swiss pharma giant Novartis.   (AP Photo/Keystone, Gaetan Bally)
The headquarters of Swiss pharmaceutical company Novartis.
The headquarters of Swiss pharmaceutical company Novartis.   (AP Photo/Keystone, Steffen Schmidt)
Misdiagnosis of breast cancer and other health problems are growing (Photo
Misdiagnosis of breast cancer and other health problems are growing (Photo   (AP Photo)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More Newser Stories

Scientists Find Gene That Triggers Menstruation

Mushrooms, Green Tea Cut Breast Cancer Risk

Migraines Lower Breast Cancer Risk: Study

Cuppa Joe Could Shrink Your C-Cup

Drug Therapy Cuts Risk of Breast Cancer Relapse


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne